Page last updated: 2024-09-03
elacridar and ML240
elacridar has been researched along with ML240 in 1 studies
Compound Research Comparison
| Studies (elacridar) | Trials (elacridar) | Recent Studies (post-2010) (elacridar) | Studies (ML240) | Trials (ML240) | Recent Studies (post-2010) (ML240) |
|---|---|---|---|---|---|
| 284 | 8 | 119 | 15 | 0 | 13 |
Protein Interaction Comparison
| Protein | Taxonomy | elacridar (IC50) | ML240 (IC50) |
|---|---|---|---|
| Valosin-containing protein | Homo sapiens (human) | 9.67 | |
| Transitional endoplasmic reticulum ATPase | Homo sapiens (human) | 3.4187 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Other Studies
1 other study(ies) available for elacridar and ML240
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |